Interrogating the precancerous evolution of pathway dysfunction in lung squamous cell carcinoma using XTABLE.

Matthew Roberts1,2, Julia Ogden2,3, A S Mukarram Hossain1,2

  • 1Cancer Biomarker Centre, Cancer Research UK Manchester Institute, The University of Manchester, Macclesfield, United Kingdom.

Elife
|March 9, 2023
PubMed
Summary

Researchers developed XTABLE, an application integrating transcriptomic data from lung squamous cell carcinoma (LUSC) premalignant lesions (PMLs). This tool aids in discovering early detection biomarkers and understanding LUSC progression.